Continued experiences with Estracyt in the treatment of advanced prostatic cancer
Jönsson, G.
Nordisk Medicin 85(6): 186-187
1971
ISSN/ISBN: 0029-1420 PMID: 5547362 Document Number: 33767
Document emailed within 1 workday
Related Documents
Yamanaka, H.; Shida, K. 1984: Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt" Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(3): 537-544Hata, M. 1988: Stage D1 prostatic cancer benefited by a single regimen of Estracyt Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(5): 1787-1790
Forshell, G.P.; Müntzing, J.; Ek, A.; Lindstedt, E.; Dencker, H. 1976: The absorption metabolism, and excretion of Estracyt (NSC 89199) in patients with prostatic cancer Investigative Urology 14(2): 128-131
Nishio, S.; Kishimoto, T.; Maekawa, M.; Kawakita, J.; Hayahara, N.; Yuki, K.; Morikawa, Y.; Yasumoto, R.; Kato, Y.; Funai, K. 1986: Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer Hinyokika Kiyo. Acta Urologica Japonica 32(11): 1763-1770
Gustafson, A.; Persson, B.; Tisell, L.E.; Wiklund, O.; Ohlson, R. 1977: Treatment of oral estramustine phosphate (Estracyt) in prostatic carcinoma: influences on lipid and carbohydrate metabolism Investigative Urology 15(3): 220-224
Fosså, S.D.; Miller, A. 1975: Treatment of advanced prostatic cancer Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 95(13): 811-814
Murray, R.; Pitt, P. 1987: Aminoglutethimide in the treatment of advanced prostatic cancer Progress in Clinical and Biological Research 243a: 275-282
Mahler, C.; Verhelst, J.; Denis, L. 1996: New molecules and treatment modulation in advanced prostatic cancer Acta Urologica Belgica 64(2): 95-98
Sarfaty, G.A.; Alder, S.J.; McLean, R.G. 1984: A pilot study of flutamide. a new agent in the treatment of advanced prostatic cancer Medical Journal of Australia 140(4): 219-221
Nilsson, T. 1980: Estracyt--clinical experiences Scandinavian Journal of Urology and Nephrology. Supplementum 55: 135-138
Porena, M.; Rosi, P.; Valli, P.P.; Cesaroni, S.; Mearini, E.; Marzi, M. 1994: Locally advanced prostatic cancer and systemic involvement Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 66(4 Suppl): 179-181
Varenhorst, E.; Carlsson, P.; Hagström, I.; Lindahl, T.; Löfman, O.; Brage, H.N.; Pedersen, K.; Wägermark, J. 1996: Experiences from six years' examinations of prostatic cancer. Mass screening is not of immediate interest! Lakartidningen 93(35): 2940-2946
Pummer, K. 1991: Epirubicin plus flutamide and orchidectomy in previously untreated advanced prostatic cancer Seminars in Oncology 18(5 Suppl 6: 26-28
Lohse, R.; Schubert, J. 1972: Treatment of advanced metastasizing prostatic carcinoma Das Deutsche Gesundheitswesen 27(26): 1238-1241
Okumura, S.; Hasegawa, J.; Ohhara, M.; Kawamura, N.; Abe, H.; Yui, Y.; Kanamori, S.; Yoshida, K.; Nishimura, T.; Tomita, M. 1984: Treatment of advanced prostatic carcinoma with cis-diamminedichloroplatinum Hinyokika Kiyo. Acta Urologica Japonica 30(12): 1801-1807
Rafla, S.; Johnson, R. 1974: The treatment of advanced prostatic carcinoma with medroxyprogesterone Current Therapeutic Research 16(4): 261-267
Vachalovský, V.; Vomácka, V. 1988: Orimeten in the treatment of advanced prostatic carcinoma Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 67(10): 666-670
Matzkin, H.; Greenstein, A.; Kaver, I.; Braf, Z. 1989: Use of gonadotropin-releasing hormone analogue in advanced prostatic cancer: 3 years clinical experience Israel Journal of Medical Sciences 25(7): 388-392
Nagel, R. 1980: Practical limitations of a controlled multicenter therapeutic study with the example of advanced inoperable prostatic cancer Verhandlungen der Deutschen Gesellschaft für Innere Medizin 86: 1304-1316
Korczak, D.; Golomb, J.; Siegel, Y.; Lindner, A. 1988: Treatment of advanced prostatic carcinoma with LHRH analogue Harefuah 115(5-6): 109-111